Listed

BioCardia, Inc.: Form 10-K for the period ended Dec 31, 2012

Filed with the SEC on Mar 22, 2013 and accepted by EDGAR at Mar 22, 2013, 15:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2012-01-01 to 2012-12-31$0us-gaap:CostOfRevenue
Gross profit12 months2012-01-01 to 2012-12-31$62.0kus-gaap:GrossProfit
Operating income12 months2012-01-01 to 2012-12-31−$339.0kus-gaap:OperatingIncomeLoss
Net income12 months2012-01-01 to 2012-12-31$305.0kus-gaap:NetIncomeLoss
Diluted EPS12 months2012-01-01 to 2012-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)12 months2012-01-01 to 2012-12-31230,293,141 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2012-01-01 to 2012-12-31−$310.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2012-01-01 to 2012-12-31$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-12-31$13.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-12-31$13.3mus-gaap:AssetsCurrent
Total assetsAt period end2012-12-31$13.3mus-gaap:Assets
Total liabilitiesAt period end2012-12-31$12.0kus-gaap:Liabilities
Shareholders' equityAt period end2012-12-31$13.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001136261-13-000152. Last ingested by Listed: Nov 13, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.